| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 381.95M | 305.38M | 257.44M | 200.03M | 147.50M |
| Gross Profit | 0.00 | 174.80M | 149.68M | 117.30M | 84.82M |
| EBITDA | 104.70M | 47.13M | 67.09M | 65.18M | 49.27M |
| Net Income | 933.00K | -7.26M | 21.82M | 34.71M | 26.65M |
Balance Sheet | |||||
| Total Assets | 1.14B | 1.02B | 905.10M | 675.89M | 621.82M |
| Cash, Cash Equivalents and Short-Term Investments | 149.86M | 64.73M | 97.22M | 48.86M | 39.33M |
| Total Debt | 492.30M | 322.88M | 264.57M | 198.52M | 195.96M |
| Total Liabilities | 628.55M | 485.65M | 401.22M | 275.68M | 277.19M |
| Stockholders Equity | 510.86M | 533.94M | 503.88M | 400.22M | 344.63M |
Cash Flow | |||||
| Free Cash Flow | 49.88M | 69.12M | 75.14M | 44.84M | 24.86M |
| Operating Cash Flow | 56.49M | 78.69M | 81.29M | 53.31M | 28.86M |
| Investing Cash Flow | -113.09M | -89.11M | -121.23M | -25.54M | -190.34M |
| Financing Cash Flow | 122.35M | 3.61M | 91.17M | -24.75M | 169.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.47B | 20.62 | 8.35% | 3.40% | -28.04% | -102.43% | |
72 Outperform | £219.25M | 13.32 | 7.58% | 5.14% | -13.29% | 63.87% | |
72 Outperform | £1.08B | 22.35 | 23.86% | 3.11% | 7.13% | -1.52% | |
70 Outperform | £2.17B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £2.23B | 52.21 | -3.61% | 1.03% | 16.90% | -165.00% | |
65 Neutral | £2.05B | 21.09 | 49.89% | 2.43% | 17.97% | 25.51% |